Home/Filings/4/0001035267-25-000198
4//SEC Filing

GUTHART GARY S 4

Accession 0001035267-25-000198

CIK 0001035267other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 1:02 PM ET

Size

15.2 KB

Accession

0001035267-25-000198

Insider Transaction Report

Form 4
Period: 2025-07-28
GUTHART GARY S
President & COO
Transactions
  • Sale

    Common Stock

    2025-07-28$495.24/sh1,400$693,33718,520 total(indirect: By Trust)
  • Gift

    Common Stock

    2025-07-2810,5001,204,863 total(indirect: By Trust)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-07-287,8930 total
    Exercise: $59.46Exp: 2026-02-16Common Stock (7,893 underlying)
  • Sale

    Common Stock

    2025-07-28$495.23/sh1,400$693,32618,520 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock

    2025-07-28$59.46/sh+7,893$469,33521,080 total
  • Sale

    Common Stock

    2025-07-28$498.64/sh7,893$3,935,75613,187 total
Footnotes (6)
  • [F1]The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $494.33 to $500.00 as follows: 475 shares sold at $494.33 to $495.16; 202 shares sold at $495.79 to $496.62; 1,045 shares sold at $496.81 to $496.87; 1,996 shares sold at $498.06 to $499.00; and 4,175 shares sold at $499.20 to $500.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 527 shares sold at $493.85 to $494.81; 569 shares sold at $494.97 to $495.72; and 304 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 320 shares sold at $493.85 to $494.85; 806 shares sold at $494.87 to $495.62; and 274 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F5]The shares were donated to a Donor Advised Fund (DAF) in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
  • [F6]Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Issuer

INTUITIVE SURGICAL INC

CIK 0001035267

Entity typeother

Related Parties

1
  • filerCIK 0001280628

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 1:02 PM ET
Size
15.2 KB